Variant report

Variant	rs16918322
Chromosome Location	chr9:101922018-101922019
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:101921262..101923800-chr9:101929228..101931291,2	K562	blood:
2	chr9:101918300..101922228-chr9:101930528..101933247,3	K562	blood:
3	chr9:101920629..101922508-chr9:101923371..101925583,4	K562	blood:
4	chr9:101920298..101922572-chr9:101925765..101928524,3	K562	blood:
5	chr9:101920629..101922508-chr9:101923371..101925010,2	K562	blood:
6	chr9:101836496..101838149-chr9:101921084..101922742,2	K562	blood:
7	chr9:101915684..101917532-chr9:101919220..101922138,2	MCF-7	breast:

No data

Extended variants
information (count: 14 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:12)

rs_ID	r²[population]
rs11466456	0.88[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs11568756	1.00[YRI][hapmap]
rs11568785	1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs11568803	0.93[AFR][1000 genomes];0.93[AMR][1000 genomes]
rs7033283	0.90[AFR][1000 genomes]
rs7034462	0.90[AFR][1000 genomes]
rs7034867	0.93[AFR][1000 genomes]
rs7035064	0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs7850895	1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs7859820	0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs7860686	0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs928180	1.00[CEU][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv893619	chr9:101835165-101936231	Enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region miRNA target site	13 gene(s)	inside rSNPs	diseases
2	nsv831666	chr9:101874985-102018690	Weak transcription Flanking Active TSS Enhancers Genic enhancers Strong transcription Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:33 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:101908600-101924600	Weak transcription	Gastric	stomach
2	chr9:101911400-101925000	Weak transcription	Dnd41	blood
3	chr9:101912400-101922200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
4	chr9:101912600-101932200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr9:101914800-101925000	Weak transcription	Aorta	Aorta
6	chr9:101914800-101927600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr9:101914800-101929800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
8	chr9:101915200-101925000	Weak transcription	Primary T cells from cord blood	blood
9	chr9:101915400-101927800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
10	chr9:101916000-101929600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr9:101916200-101924600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr9:101917200-101924600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr9:101920800-101922200	Enhancers	Placenta	Placenta
14	chr9:101920800-101922400	Enhancers	K562	blood
15	chr9:101921400-101922800	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr9:101921600-101922200	Enhancers	Lung	lung
17	chr9:101921600-101922800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr9:101921800-101922200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr9:101921800-101922200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr9:101921800-101922400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr9:101921800-101922400	Enhancers	HUES64 Cell Line	embryonic stem cell
22	chr9:101921800-101922400	Bivalent Enhancer	HUVEC	blood vessel
23	chr9:101921800-101922600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
24	chr9:101921800-101922800	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr9:101922000-101922200	Enhancers	H1 Cell Line	embryonic stem cell
26	chr9:101922000-101922200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr9:101922000-101922200	Enhancers	Primary hematopoietic stem cells	blood
28	chr9:101922000-101922200	Enhancers	Placenta Amnion	Placenta Amnion
29	chr9:101922000-101922400	Enhancers	Primary neutrophils fromperipheralblood	blood
30	chr9:101922000-101922600	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr9:101922000-101922600	Enhancers	H9 Cell Line	embryonic stem cell
32	chr9:101922000-101922600	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr9:101922000-101922800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links